Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnergean Oil & Gas Regulatory News (ENOG)

Share Price Information for Energean Oil & Gas (ENOG)

Share Price is delayed by 15 minutes
Get Live Data
723.00    -7.00 (-0.96%)
Bid:
729.50
Ask:
730.50
Spread: 1.00 (0.137%)
Market Cap: £1.34b
ENOG Live PriceLast checked at - London Stock Exchange

Intraday Energean Oil & Gas Share Chart

Stabilisation Notice

10 Nov 2021 10:18

RNS Number : 9502R
J.P. Morgan Securities PLC.
10 November 2021
 

10th Nov 21

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Energean PLC

Pre-stabilisation Period Announcement

J.P. Morgan Securities plc, (contact: Emma Lovett 0207 134 2468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).

The securities:

Issuer:

Energean PLC

Guarantor (if any):

N/A

Aggregate nominal amount:

USD 400mm

Description:

USD 5.5yr-Non-Call-2yr FXD Senior Secured Notes

Listing: The International Stock Exchange

Offer price:

TBC

Other offer terms:

Denoms: USD 200,000 x USD 1,000

Stabilisation:

Stabilisation Manager(s):

J.P. Morgan Securities plc (Stabilisation coordinator)

ING (Stabilisation Manager(s))

BNP Paribas (Stabilisation Manager(s))

Credit Suisse (Stabilisation Manager(s))

Deutsche Bank (Stabilisation Manager(s))

Goldman Sachs International (Stabilisation Manager(s))

Morgan Stanley (Stabilisation Manager(s))

Natixis (Stabilisation Manager(s))

Poalim IBI (Stabilisation Manager(s))

Stabilisation period expected to start on:

10th Nov 21

Stabilisation period expected to end no later than:

10th Dec 21

Existence, maximum size and conditions of use of overallotment facility:

The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above.

Stabilisation trading venue:

Over the counter, TBC

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAEAEFEFFXFFFA
Date   Source Headline
23rd Sep 20254:27 pmRNSDirector Declaration
22nd Sep 20254:07 pmRNSHolding(s) in Company
11th Sep 20257:01 amRNSEnergean Israel Half Year 2025 Accounts
11th Sep 20257:00 amRNS2Q 2025 Dividend Declaration
11th Sep 20257:00 amRNSResults for Half Year Ended 30 June 2025
8th Sep 20256:17 pmRNSBlock Listing Six Monthly Return
14th Aug 20253:48 pmRNSDirector Declaration
25th Jul 202512:27 pmRNSReplacement: Holding(s) in Company
23rd Jul 20251:43 pmRNSHolding(s) in Company
10th Jul 20253:33 pmRNSDirector/PDMR Shareholding
10th Jul 202510:17 amRNSDirector/PDMR Shareholding
25th Jun 20259:05 amRNSRestart of Production from the Energean Power FPSO
13th Jun 20258:51 amRNSTemporary Suspension of Production from FPSO
11th Jun 20253:42 pmRNSDirector/PDMR Shareholding
3rd Jun 20251:38 pmRNSDirector/PDMR Shareholding
29th May 20254:19 pmRNSDirector/PDMR Shareholding
22nd May 20251:35 pmRNSResult of AGM
22nd May 20257:01 amRNSEnergean Israel 1Q 2025 Accounts
22nd May 20257:00 amRNS1Q 2025 Dividend Declaration
22nd May 20257:00 amRNSTrading Statement & Operational Update
30th Apr 20254:23 pmRNSDirector/PDMR Shareholding
17th Apr 20251:00 pmRNSAnnual Financial Report and Notice of AGM
14th Apr 20257:00 amRNSNew GSPA Signed
10th Apr 20253:56 pmRNSDirector/PDMR Shareholding
8th Apr 20255:00 pmRNSHolding(s) in Company
8th Apr 20254:40 pmRNSDirector/PDMR Shareholding
4th Apr 20253:23 pmRNSDirector/PDMR Shareholding
31st Mar 20253:49 pmRNSDirector/PDMR Shareholding
31st Mar 20253:37 pmRNSTotal Voting Rights
27th Mar 20254:13 pmRNSDirector/PDMR Shareholding
26th Mar 20254:30 pmRNSDirector/PDMR Shareholding
26th Mar 20254:25 pmRNSDirector/PDMR Shareholding
26th Mar 20254:25 pmRNSDirector/PDMR Shareholding
26th Mar 20254:15 pmRNSDirector/PDMR Shareholding
26th Mar 20254:15 pmRNSDirector/PDMR Shareholding
26th Mar 20257:00 amRNSDirector/PDMR Shareholding
25th Mar 20252:41 pmRNSDirector/PDMR Shareholding
25th Mar 20251:49 pmRNSDirector/PDMR Shareholding
24th Mar 20254:13 pmRNSDirector/PDMR Shareholding
24th Mar 20254:08 pmRNSDirector Declaration
21st Mar 20257:00 amRNSTermination of Strategic Sale
20th Mar 20257:01 amRNSEnergean Israel Full Year 2024 Accounts
20th Mar 20257:00 amRNS2024 Full Year Results
18th Mar 202511:15 amRNSBlock Listing Application
17th Mar 20257:00 amRNSUpdate on Strategic Sale
10th Mar 20254:19 pmRNSBlock Listing Six Monthly Return
3rd Mar 202512:32 pmRNSTASE Ex-Dividend Date Correction
3rd Mar 20257:00 amRNSTerm Loan Signed For $750 Million
27th Feb 20257:00 amRNSDirectorate and Board Committee Membership Changes
27th Feb 20257:00 amRNS4Q 2024 Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.